Columbia Missourian12h
FDA approves first new schizophrenia drug in more than 30 years
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner's Epilepsy Potential
Xenon has promising Phase 2 data for MDD treatment, robust financials, and a potential in niche markets, despite premium ...
Rolling Out2d
Why you need magnesium and potassium in your diet
Discover why magnesium and potassium are vital for your health and how they support heart function, muscle recovery, and ...
Healio2d
FDA grants fast-track designation to small molecule for Fragile X
The FDA has granted fast-track designation to an investigational small molecule to treat individuals with Fragile X syndrome, ...
TipRanks on MSN4d
Actinogen’s Lead Drug Xanamem Gains WHO Recognition Amid Ongoing Trials
Actinogen Medical Limited ( ($AU:ACW) ) has provided an announcement. Actinogen Medical has announced the WHO’s granting of the nonproprietary ...
Daijiworld6d
Beta-blockers well-tolerated drug, does not commonly lower potassium levels: Experts
Beta blockers are not commonly known to lower potassium levels, and are a well-tolerated drug, said experts on Friday, expressing concerns on government body’s alert on these commonly used medicines ...